SRC family kinases: potential targets for the treatment of human cancer and leukemia.
about
c-Src protein kinase inhibitors block assembly and maturation of dengue virusDual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humansInhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathwaySrc kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionmaSrc kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppressionA phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.The target discovery process.Src protein tyrosine kinase family and acute inflammatory responses.Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin.Emerging therapies for colorectal cancer.Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors.Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization.STAT3 as a target for inducing apoptosis in solid and hematological tumorsSrc-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src.PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines.N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl.Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma.Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms.c-src activating mutation analysis in Chinese patients with colorectal cancer.Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and extracellular signal-regulated kinases 1/2 pathways in MCF-7 cells.Spectroscopic characterization of the SH2- and active site-directed peptide sequences of a bivalent Src kinase inhibitor.Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells.Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.[Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP].
P2860
Q27478101-9F62750D-62DF-45AF-8633-875378E881AEQ30009087-329EC0A4-4764-4916-9E9C-A0A57C78B538Q30437935-3EE56098-EB38-4E8C-AF4B-7C43155DB4B1Q33884626-76FE316A-D5ED-4481-B3B7-A657D7B62838Q33888940-9F904C14-E5BC-4821-95D7-15218721E62CQ33995107-B8AFCAE1-80B4-4494-BD33-F53A0676BD14Q34194110-0C896E83-D73B-4E55-A37D-4A6FA91E1E1BQ36059506-44382EAC-7185-41CE-88BA-D8B247DCC8D2Q36438267-408A878B-C5AC-42C0-84EB-759D7DE27FCAQ36585589-EB571396-049E-49D4-A83F-BA29470C4AAFQ36821373-2D244EF5-847F-4519-8122-893AB691F106Q36864805-CDF8A356-9FF8-4507-BD75-DE5E00101F0DQ37015035-5E2D037A-1F12-4D6C-B9AA-6FC7709F8097Q37029162-E7FDF594-48F5-4F43-9546-3B4020DB343CQ37059746-F24FBE26-D398-4D19-960C-130FB2BC3095Q38827105-5F7CB519-114C-48D1-8FBA-DBEBE68A4D83Q39263745-AD05AA98-1A6F-4B3A-9BD2-F3A821696503Q39459749-70390491-25F4-43D3-9645-B9CD3EFA1045Q39665256-92D2F659-E129-4457-9672-7453F658C8F0Q40416325-DD6C2027-B3BB-4F41-9C69-0FEDF8E7FBF8Q42266981-9CFA019C-6B47-4656-900B-44893C280BDBQ42424428-B371FF5E-5CFB-472A-B981-0D5B06F948C4Q43874359-AB0D12DC-8C91-491B-8861-F045731043A7Q45934077-513F8771-87BC-4CB7-9233-0BE76EB94740Q46645256-7FC29EAE-6B3D-43D3-9851-782450C9056CQ49887894-E93F435C-D0CA-47B1-B00E-5F2482CF2CB9Q54482794-7B2196FB-8CBA-41D4-BBA3-BA1EA59FFE4B
P2860
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
@ast
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
@en
type
label
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
@ast
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
@en
prefLabel
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
@ast
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
@en
P2093
P356
P1476
SRC family kinases: potential targets for the treatment of human cancer and leukemia.
@en
P2093
Doriano Fabbro
Markus Warmuth
Nathanael Gray
Robert Damoiseaux
P304
P356
10.2174/1381612033454126
P577
2003-01-01T00:00:00Z